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A B S T R A C T
The appropriate development and regulation of neuronal morphology are important to establish functional
neuronal circuits and enable higher brain function of the central nervous system. R-Ras, a member of the Ras
family of small GTPases, plays crucial roles in the regulation of axonal morphology, including outgrowth,
branching, and guidance. GTP-bound activated R-Ras reorganizes actin ﬁlaments and microtubules through
interactions with its downstream eﬀectors, leading to the precise control of axonal morphology. However, little
is known about the upstream regulatory mechanisms for R-Ras activation in neurons. In this study, we found that
brain-derived neurotrophic factor (BDNF) has a positive eﬀect on endogenous R-Ras activation and promotes R-
Ras-mediated axonal growth. RNA interference knockdown and overexpression experiments revealed that
RasGRF1, a guanine nucleotide exchange factor (GEF) for R-Ras, is involved in BDNF-induced R-Ras activation
and the promotion of axonal growth. Phosphorylation of RasGRF1 by protein kinase A at Ser916/898 is needed
for the full activation of its GEF activity and to facilitate Ras signaling. We observed that BDNF treatment
markedly increased this phosphorylation. Our results suggest that BDNF is one of the critical extrinsic regulators
for R-Ras activation, and that RasGRF1 is an intrinsic key mediator for BDNF-induced R-Ras activation and R-
Ras-mediated axonal morphological regulation.
1. Introduction
Neurons project single axons that carry information to target cells,
and they also have a set of multiple branched dendrites that receive
signals from other neurons. The morphological structures of highly
polarized neurons are essential to form complicated neuronal networks
for proper function. Multiple steps of axonal development, including
outgrowth, branching, and guidance, are strictly controlled by extrinsic
cues and intrinsic signals [1]. Previous studies revealed that Ras and
Rho family small GTPases function in the regulation of axonal mor-
phology by controlling the dynamics of the cytoskeleton such as actin
ﬁlaments and microtubules [2]. It is well known that members of the
small GTPases serve as molecular switches of intracellular signaling
pathways by cycling between a GDP-bound inactive state and a GTP-
bound active state, and only activated forms interact with their
downstream eﬀectors, leading to diﬀerent biological eﬀects.
The Ras superfamily comprises a large group of structurally and
functionally related small GTPases [3]. R-Ras-subfamily members, R-
Ras, TC21/R-Ras2, and M-Ras/R-Ras3, exhibit relatively high
homology and form a distinct branch of the classical Ras subfamily [4].
Extensive studies have clariﬁed the signaling pathways linking acti-
vated R-Ras to its downstream eﬀectors. For example, R-Ras is involved
in the activation of phosphatidylinositol 3-kinase (PI3K) but not of
extracellular signal-regulated kinase (ERK), and in the regulation of
integrin activity, which is important for cell-substrate adhesion [3,5].
We previously reported that R-Ras regulates both actin and microtubule
cytoskeletons in neurons during axonal development. We demonstrated
that R-Ras is needed for the microtubule-dependent regulation of ax-
onal morphology through PI3K signaling [6]. On the other hand, we
recently found that afadin, an actin scaﬀold protein, is a binding
partner for R-Ras, functioning as a regulator of axon branching through
F-actin reorganization [7,8]. Compared with the downstream me-
chanisms of R-Ras signaling, little is known about the upstream reg-
ulators for R-Ras activity in neurons. With regard to the molecular
mechanisms of R-Ras inactivation, two major repulsive axon guidance
factors, ephrins and semaphorins, inactivate R-Ras to induce axonal
repulsion; ephrins inactivate R-Ras activity through tyrosine phos-
phorylation and p120RasGAP [9], whereas plexins, receptors for
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semaphorins, directly inactivate R-Ras [10–12]. However, it remains
unclear which extracellular molecules or stimuli activate R-Ras in
neurons.
Brain-derived neurotrophic factor (BDNF), one of the major neu-
rotrophic factors, has long been known to play many vital roles in the
brain, including in neuronal diﬀerentiation, survival, growth, synapse
formation, and plasticity [13]. BDNF is abundantly and widely ex-
pressed in the mammalian brain, and its expression increases until
reaching its maximum level after birth [14]. In neuropsychiatry, BDNF
has been associated with several disorders such as depression and bi-
polar disorder [15,16]. Therefore, many researchers have been in-
vestigating factors that can elevate BDNF levels in animals and humans
Fig. 1. BDNF activates R-Ras and promotes R-
Ras-mediated axonal growth. (A) Cortical
neurons at 3 DIV were treated with 50 ng/mL
of BDNF or vehicle control for 30min.
Activated R-Ras was isolated with GST-Ras-
binding domain (RBD) of c-Raf-1 and detected
by the R-Ras speciﬁc antibody. (B)
Densitometry analysis was performed, and
GTP-R-Ras/total R-Ras ratio was determined.
Relative R-Ras activity compared to vehicle-
treated cells is shown. Data are presented as
the means ± SEM of four independent pre-
parations, **p < 0.01. (C) Neurons were
transfected with YFP and shRNAs at 1 DIV,
then 50 ng/mL of BDNF was added to 2 DIV
culture medium, and incubated for 24 h before
ﬁxation. Scale bar, 50 µm. (D, E) The eﬀects on
axon length (D) and branching (E) were
quantitatively analyzed and expressed as
means ± SEM of 54 cells in three independent
preparations, *p < 0.05; ***P < 0.001; ns,
not signiﬁcantly diﬀerent.
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based on the hypothesis that an increased BDNF level can improve
brain health. Regarding neuronal morphological regulation, BDNF
plays essential roles in the regulation of axonal diﬀerentiation,
outgrowth, and branching [17–19]. However, to our knowledge, there
is no report demonstrating the relationship between BDNF and R-Ras in
the regulation of axonal morphology.
Fig. 2. Knockdown of endogenous RasGRF1
suppresses the BDNF-induced promotion of ax-
onal growth. (A) Neurons were nucleofected
with the indicated shRNAs before plating and
lysed at 3 DIV. The eﬀects of RasGRF1 shRNAs
were veriﬁed by SDS-PAGE and immunoblot-
ting. (B) Neurons were transfected with YFP
and shRNAs at 1 DIV, then 50 ng/mL of BDNF
was added to 2 DIV culture medium, and in-
cubated for 24 h before ﬁxation. Scale bar,
50 µm. (C, D) The eﬀects on axon length (C) and
branching (D) were quantitatively analyzed and
expressed as means ± SEM of 54–55 cells in
three independent preparations, **P < 0.01;
***P < 0.001; ns, not signiﬁcantly diﬀerent.
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The RasGRF family, RasGRF1 and RasGRF2, harbor a complex array
of structural motifs, including two pleckstrin homology (PH) domains, a
coiled-coil and IQ motif, a Dbl homology (DH) domain acting as a
catalyzer of GDP/GTP exchange on the Rac1 small GTPase, a Ras ex-
change motif, and CDC25 Ras exchange domain common to all Ras
GEFs [20,21]. Although RasGRF1 and RasGRF2 have the same domain
architecture, RasGRF2 is unable to activate R-Ras due to sequence
diﬀerences in their catalytic domains, which make RasGRF2 unable to
recognize the lipid moieties bound to R-Ras [22]. Thus, we focused only
on RasGRF1 as a candidate regulator for R-Ras activation and R-Ras-
mediated axonal morphological changes in this study. Functional ana-
lyses of RasGRF1 KO mice have demonstrated speciﬁc involvement of
this protein in memory formation [23,24]. Moreover, at the cellular
level, RasGRF1 was found to be phosphorylated at speciﬁc sites by a
variety of intracellular kinases in response to several extracellular sti-
muli. Nerve growth factor (NGF), carbachol, forskolin, serotonin, and
NMDA stimulation have been reported to increase phosphorylation of
RasGRF1 at Ser916 in the mouse sequence or its equivalent (e.g.,
Ser898 in rats and Ser927 in humans) [25–28]. This phosphorylation,
which is mediated by protein kinase A (PKA), is necessary for a sig-
niﬁcant increase in its intrinsic GEF activity against Ras proteins. As for
the mechanisms of R-Ras activation, elevation of the intracellular cyclic
AMP (cAMP) level is known to induce R-Ras activation [8]. These re-
sults gave rise to the hypothesis that BDNF activates R-Ras through
RasGRF1 phosphorylation, promoting axonal outgrowth. In the present
study, we demonstrated that BDNF treatment triggers endogenous R-
Ras activation through PKA-mediated RasGRF1 phosphorylation, which
regulates R-Ras-mediated axonal growth in primary cultured rat cor-
tical neurons.
2. Materials and methods
2.1. Plasmids
The glutathione S-transferase (GST)-fused Ras-binding domain
(RBD) of c-Raf-1, R-Ras shRNA expression vector, and control shRNA
have been described previously [10,11,29]. The shRNA constructs for
rat RasGRF1 were designed to target 21 nucleotides of the rat tran-
script. The target sequences were as follows: #A (nucleotides 723–743,
5´- GAACCAGGTGGTGTTCAGCAT -3´), #B (nucleotide 3541–3561, 5´-
GACGGCCTGGTCAACTTCTCC -3´). These shRNAs were expressed
using pSilencer-2.1 (Invitrogen). RasGRF1 cDNA was purchased from
Addgene and subcloned into the pCXN2 vector with a Flag tag se-
quence.
2.2. Reagents and antibodies
The following reagents were purchased commercially: Poly-L-lysine,
dbcAMP, forskolin, and the pharmacological Trk receptor inhibitor
K252a (Sigma-Aldrich); recombinant human BDNF (PeproTech); and
Fig. 3. Overexpression of RasGRF1 promotes axonal growth. (A) Neurons were transfected with YFP and RasGRF1 at 1 DIV, then 50 ng/mL of BDNF was added to 2
DIV culture medium, and incubated for 24 h before ﬁxation. Scale bar, 50 µm. (B, C) The eﬀects on axon length (B) and branching (C) were quantitatively analyzed
and expressed as means ± SEM of 57 cells in three independent preparations, *p < 0.05; **P < 0.01; ***P < 0.001; ns, not signiﬁcantly diﬀerent.
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the pharmacological PKA inhibitor H-89 (Cell Signaling Technology).
We used the following antibodies: a rabbit polyclonal antibody for R-
Ras was obtained as described previously [8]. The other antibodies
were purchased commercially: mouse monoclonal antibodies againstα-
tubulin (B-5-1-2) and Flag (M2; Sigma-Aldrich); rabbit polyclonal an-
tibodies against ERK and phospho-RasGRF1 (Ser916/898), and a rabbit
monoclonal anti-T202/Y204 phospho-ERK antibody (Cell Signaling
Technology); a rabbit polyclonal antibody against RasGRF1 (C-20;
Santa Cruz Biotechnology); Alexa Fluor-conjugated secondary anti-
bodies (Invitrogen); and horseradish peroxidase (HRP)-conjugated
secondary antibodies (Dako).
2.3. Cell culture and transfection
Cortical neurons were prepared from the embryonic day 19 rat
brains as described previously [7,8]. The dissociated neurons were
seeded on poly-L-lysine-coated glass cover slips (circular, 13mm in
diameter) at a density of 2.5× 104 cells or plastic dishes (60mm in
diameter) in DMEM containing 10% FBS, 4mM glutamine, 100 units/
mL of penicillin, and 0.1 mg/mL of streptomycin and cultured under
humidiﬁed air containing 5% CO2 at 37 °C. After 4 h, the medium was
replaced with Neurobasal medium (Invitrogen) containing 2% B27
supplement (Invitrogen), 0.5mM GlutaMAX (Invitrogen), 50 units/mL
penicillin, and 0.05mg/mL streptomycin, and neurons were cultured
under humidiﬁed air containing 5% CO2 at 37 °C. For knockdown and
overexpression experiments, cortical neurons were transfected with the
indicated plasmids at 1 d in vitro (DIV) with Lipofectamine 2000 ac-
cording to the manufacturer's instructions. For analysis of R-Ras ac-
tivity, 50 ng/mL BDNF was added to 3 DIV culture medium and in-
cubated for 30min. For neuronal morphological analysis, 50 ng/mL
BDNF was added to 2 DIV culture medium and incubated for 24 h
before ﬁxation. For analysis of Ser916/898 phosphorylation level of
RasGRF1, 50 ng/mL BDNF, 1mM dbcAMP, 20 μM forskolin were added
to 3 DIV culture medium and incubated for 30min. Pretreatment with
pharmacological inhibitors (100 nM K252a or 10 μM H-89) was per-
formed for 45min. All animal experiments were conducted according to
the guidelines of the Kyoto University Research Committee.
2.4. Nucleofection
Cortical neurons (2.5× 106 cells) were suspended in 100 μl of
Nucleofector solution (Lonza), mixed with total 3 μg of plasmid for
knockdown of endogenous RasGRF1 (YFP:shRNA,1:3), and nucleo-
fected (program O-003) before plating using Nucleofector device
(Lonza).
2.5. Pull-down assay
For the measurement of R-Ras activity, a pull-down assay was
performed as described previously [29]. Cortical neurons (2.0× 106
cells) at 3 DIV treated with 50 ng/mL BDNF for 30min were lysed on
dishes with ice-cold cell lysis buﬀer (25mM HEPES-NaOH, pH 7.5,
150mM NaCl, 10mM MgCl2, 0.5% Nonidet P-40, 0.5% sodium deox-
ycholate, 1 mM EDTA, 25mM NaF, 1mM orthovanadate, 1 mM phe-
nylmethylsulphonyl ﬂuoride (PMSF), 10 μg/mL aprotinin, 10 μg/mL
leupeptin, and 1mM dithiothreitol) containing 75 μg of GST-RBD of c-
Raf-1.
2.6. Immunoblotting
Proteins were separated by SDS-PAGE and electrophoretically
transferred onto a polyvinylidene diﬂuoride membrane (Millipore). The
membrane was blocked with 3% low-fat milk in Tris-buﬀered saline
(TBS) and then incubated with primary antibodies. The primary anti-
bodies were detected with HRP-conjugated secondary antibodies and
enhanced chemiluminescence (ECL) detection Kit (GE Healthcare).
Images were captured using a LAS3000 analyzer (Fujiﬁlm) equipped
with Science Lab software (Fujiﬁlm).
2.7. Intracellular cAMP assay
The cAMP concentration was measured using Cyclic AMP XP assay
kit (Cell Signaling Technology). Brieﬂy, 3 DIV cortical neurons
(2.5× 105 cells) were treated with 50 ng/mL of BDNF or 20 μM for-
skolin (positive control) for 15min with or without pretreatment with
100 nM K252a for 45min. Then, neurons were lysed with 100 μl of lysis
buﬀer. Fifty microliters of cell lysate was transferred into microtubes,
and the cAMP concentration was measured according to the protocol
provided in the kit. In each experiment, a standard curve was generated
in parallel and used to calculate the cAMP concentration.
2.8. Immunoﬂuorescence microscopy
Immunoﬂuorescence microscopy was performed as described pre-
viously [7,8]. Primary cultured cortical neurons on cover slips were
ﬁxed with 4% paraformaldehyde in phosphate-buﬀered saline (PBS) for
20min. After residual paraformaldehyde had been quenched with
50mM NH4Cl in PBS for 10min, cells were permeabilized with 0.2%
Triton X-100 in PBS for 10min and incubated with 10% FBS in PBS for
30min. Cells were incubated with the 1st antibodies for 1 h, followed
by incubation with Alexa 594-conjugated 2nd antibody and Alexa 488-
conjugated rabbit anti-GFP antibody for 1 h. The cells on cover slips
were mounted in 90% glycerol containing 0.1% p-phenylenediamine
dihydrochloride in PBS and photographed with a Leica DC350F digital
camera system (Leica) equipped with a Nikon Eclipse E800 microscope
(Nikon). The images were arranged and labeled using Photoshop CS5.1
(Adobe).
Fig. 4. Eﬀects of BDNF on Ser916/898 phosphorylation of RasGRF1. (A)
Cortical neurons at 3 DIV were treated with 50 ng/mL of BDNF, 1mM dbcAMP,
and 20 μM forskolin for 30min. Phosphorylated RasGRF1 (Ser916/898) was
analyzed by immunoblotting with the anti-pSer916/898 antibody. (B)
Densitometry analysis was performed, and p-RasGRF1/total RasGRF1 ratio was
determined. Relative levels of p-RasGRF1/total RasGRF1 compared to vehicle-
treated cells are shown. Data are presented as the means± SEM of four in-
dependent preparations, *p < 0.05; **P < 0.01; ***P < 0.001.
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2.9. Data analysis
Densitometry analysis was performed with Multi Gauge, version 3.1
(Fujiﬁlm). Morphometric analysis of axons was performed as described
previously [7]. A cell was considered to have an axon if the length of
one neurite was at least twice as long as any other process and was
more than twice the diameter of the cell body, as described previously
[30]. The total length of axon and the number of axon tips were mea-
sured. Only processes longer than 5 µm in length were included in the
analysis [31]. Statistical signiﬁcance was established at p < 0.05 by
one-way analysis of variance (ANOVA) with post hoc test (Dunnett) or
Student's t-test using KaleidaGraph (4.5.2; Synergy Software).
3. Results
3.1. BDNF treatment increases endogenous R-Ras activity and promotes R-
Ras-mediated axonal growth
In primary cultured cortical neurons, R-Ras localizes at the axon and
its activity increases after plating, and then peaks when neuronal po-
larization and axonal formation occurs [29]. To identify the upstream
regulators of R-Ras activation, we focused on molecules that have been
reported to have positive eﬀects on axonal growth. BDNF, a neuro-
trophin, has been reported to positively regulate axonal outgrowth and
branching [18,19]. Thus, we examined the eﬀects of BDNF on R-Ras
activation by a pull-down assay with the GST-fused Ras-binding domain
(RBD) of c-Raf-1, which can selectively isolate active R-Ras [32]. After a
30-min treatment with 50 ng/mL of BDNF, the level of GTP-bound R-
Ras increased (Fig. 1A-B). We next examined whether R-Ras is involved
in the BDNF-induced axonal morphological changes using a short
hairpin RNA (shRNA) expression vector designed to target the en-
dogenous R-Ras transcript [29]. Cortical neurons were transfected with
yellow ﬂuorescent protein (YFP) and shRNA at 1 DIV, and 50 ng/mL of
BDNF was added to the culture medium at 2 DIV. After a 24-h in-
cubation, the axonal morphology was analyzed at 3 DIV (Fig. 1C-E). In
neurons transfected with control shRNA, BDNF treatment signiﬁcantly
increased not only axonal length, but also branching, which is con-
sistent with previous reports [18,19]. In contrast, expression of R-Ras
speciﬁc shRNA blocked the BDNF-induced promotion of axonal growth.
These results suggest that BDNF promotes R-Ras activation and axonal
growth through R-Ras activation.
3.2. RasGRF1 is required for the BDNF-induced promotion of axonal
growth
We next investigated the molecular events that connect extra-
cellular BDNF stimulation to intracellular R-Ras activation. In general,
activation of Ras family small GTPases requires GDP-GTP exchange
Fig. 5. Involvement of PKA and Trk receptor in
BDNF-induced Ser916/898 phosphorylation of
RasGRF1. (A, B) Cortical neurons at 3 DIV were
pretreated with 10 μM H-89 (A) or 100 nM
K252a (B) for 45min, and then treated with
50 ng/mL of BDNF for 30min. Phosphorylated
RasGRF1 (Ser916/898) was analyzed by im-
munoblotting with the anti-pSer916/898 anti-
body. (C, D) Densitometry analysis was per-
formed, and p-RasGRF1/total RasGRF1 ratio
was determined. Relative levels of p-RasGRF1/
total RasGRF1 compared to vehicle-treated
cells are shown. Data are presented as the
means ± SEM of four independent prepara-
tions, *p < 0.05; **P < 0.01; ***P < 0.001;
ns, not signiﬁcantly diﬀerent. (E) Cortical
neurons at 3 DIV were treated with 50 ng/mL
of BDNF for 15min with or without pretreat-
ment with 100 nM K252a for 45min. Then, the
intracellular cAMP concentration was mea-
sured using the Cyclic AMP XP assay kit.
Relative cAMP levels compared to vehicle-
treated cells are shown. Data are presented as
the means ± SEM of four independent pre-
parations, ns, not signiﬁcantly diﬀerent.
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catalyzed by guanine nucleotide exchange factors (GEFs). Thus, we
sought to identify a GEF linking BDNF signaling to the regulation of R-
Ras activity. RasGRF1, one of the GEFs for Ras family proteins, is highly
expressed in the brain and acts as an important component of signaling
pathways for CNS functions such as the regulation of synaptic plasticity,
learning, and memory [20,21]. It has been reported that RasGRF1 can
activate R-Ras [22]. Additionally, several reports have demonstrated
that RasGRF1 directly interacts with three Trk receptors, TrkA, TrkB,
and TrkC, which are receptors for neurotrophins [33,34]. These ﬁnd-
ings raised the possibility that RasGRF1 is involved in BDNF-TrkB sig-
naling, leading to R-Ras activation and the promotion of axonal growth.
To explore this possibility, we generated two kinds of shRNA designed
to target two diﬀerent regions of the RasGRF1 transcript. These shRNAs
eﬀectively reduced the amount of endogenous RasGRF1 in cortical
neurons (Fig. 2A). Expression of RasGRF1-speciﬁc shRNAs blocked the
promotion of axonal growth induced by BDNF treatment (Fig. 2B-D).
We next performed the overexpression experiment to examine the in-
volvement of RasGRF1 in the regulation of axonal morphology. Cortical
neurons were transfected with YFP and Flag-tagged RasGRF1 at 1 DIV,
and then treated with 50 ng/mL of BDNF at 2 DIV. After a 24-h in-
cubation, the axonal morphology was analyzed. As shown in Fig. 3,
ectopic expression of RasGRF1 promoted axonal growth, i.e., increased
axon length and branching. In addition, BDNF treatment slightly pro-
moted axonal growth in neurons transfected with RasGRF1, but a sig-
niﬁcant diﬀerence was observed only in axonal branching. Collectively,
these results suggest that RasGRF1 positively regulates the BDNF-in-
duced promotion of axonal growth.
3.3. Ser916/898 phosphorylation of RasGRF1 is enhanced by BDNF
treatment
The GEF activity of RasGRF1 is fully activated by its phosphoryla-
tion at Ser916 in the mouse sequence, equivalent to Ser898 in rats. This
phosphorylation is triggered by many extracellular stimuli such as
carbachol, forskolin, and serotonin [25,27]. In addition, nerve growth
factor (NGF) stimulation of endogenous Trk receptors induces RasGRF1
Ser916/898 phosphorylation and promotes Ras-dependent neurite
outgrowth [26]. These previous ﬁndings raised the hypothesis that
BDNF-TrkB signaling also promotes the Ser916/898 phosphorylation of
RasGRF1. To address this hypothesis, 3 DIV cortical neurons were
treated with 50 ng/mL of BDNF for 30min, and cell lysates were im-
munoblotted with the anti-pSer916/898 antibody. We also treated
neurons with 1mM dibutyryl cAMP (dbcAMP), a membrane-permeable
cAMP analogue, or 20 μM forskolin, an activator of adenylyl cyclase, as
positive controls for Ser916/898 phosphorylation. We found that
treatment with BDNF, as well as dbcAMP and forskolin, markedly in-
creased Ser916/898 phosphorylation (Fig. 4A-B). This suggests that
Ser916/898 is phosphorylated by BDNF treatment in cultured cortical
neurons.
3.4. BDNF-induced Ser916/898 phosphorylation of RasGRF1 is mediated
by PKA
Next, we sought to identify the intracellular molecular mechanisms
underlying the phosphorylation of RasGRF1 after BDNF treatment. As
the sequence around Ser916/898 is a consensus PKA substrate sequence
and this phosphorylation is reported to be induced by PKA [25,35], we
examined whether BDNF-induced Ser916/898 phosphorylation of
RasGRF1 is regulated by PKA using a pharmacological inhibitor. In the
presence of a PKA inhibitor, H-89, there was no signiﬁcant increase in
Ser916/898 phosphorylation of RasGRF1 induced by BDNF treatment
(Fig. 5A, C). Moreover, pretreatment with a Trk receptor inhibitor,
K252a, partially blocked the BDNF-induced phosphorylation (Fig. 5B,
D). These data suggest that BDNF-Trk signaling regulates PKA activity,
thereby promoting Ser916/898 phosphorylation of RasGRF1. A pre-
vious study using ﬂuorescence resonance energy transfer (FRET)
imaging sensors expressed individually in cultured neurons revealed
that bath application of BDNF increased the cAMP level and PKA ac-
tivity [36]. To quantify the changes in the intracellular cAMP con-
centration after BDNF treatment under our culture conditions, we uti-
lized a competition enzyme-linked immunoassay kit. As neurons treated
with forskolin exhibit a signiﬁcant increase in the intracellular cAMP
level [37], we used forskolin as a positive control for cAMP increase.
Following the addition of forskolin to the culture medium, a signiﬁcant
increase in the intracellular cAMP level was noted (data not shown),
indicating that this assay system can be used to measure the changes in
cAMP level under our experimental conditions. The intracellular cAMP
level in BDNF-treated neurons was higher than that in control or K252a
pretreated neurons, although the diﬀerence was not signiﬁcant
(Fig. 5E). This may be because this assay method utilized whole cell
lysate, and local and transient elevation of cAMP after BDNF treatment
may not have been clearly detected. Collectively, these results indicate
that BDNF-TrkB signaling triggers cAMP/PKA activation, resulting in
the promotion of Ser916/898 phosphorylation of RasGRF1.
4. Discussion
The ﬁndings presented here support a positive role of BDNF in en-
dogenous R-Ras activation. Moreover, we demonstrated that RasGRF1,
one of the guanine nucleotide exchange factors (GEFs) for Ras family
small GTPases, is involved in the BDNF-induced R-Ras activation and R-
Ras-mediated axonal growth. Thus, our results provide new insight into
the detailed molecular mechanisms of how endogenous R-Ras activity is
regulated in response to extracellular stimuli in neurons.
We previously reported that R-Ras, a Ras family small GTPase, plays
essential roles in axonal formation, elongation, and guidance
[10,11,29]. Activated R-Ras speciﬁcally interacts with its downstream
eﬀectors, leading to the regulation of actin or microtubule cytoskele-
tons [6–8]. Regarding the regulatory mechanisms of endogenous R-Ras
activity, ephrins, repulsive axon guidance molecules, inactivate R-Ras
activity through R-Ras tyrosine phosphorylation and p120RasGAP to
induce axonal repulsion [9]. Plexins, receptors for semaphorins, have
also been reported to directly inactivate R-Ras in cultured neurons,
inducing axonal repulsion [10–12]. It is well known that repulsive
guidance factors, including ephrins and semaphorins, have negative
eﬀects on axonal growth such as retraction of axonal structure [38,39].
Recent studies raised the possibility that extracellular factors, which
play positive roles in axonal growth, may have the ability to activate R-
Ras activity. In light of the previous observation that BDNF promotes
axonal diﬀerentiation, outgrowth, and branching [17–19], we focused
on BDNF as a candidate upstream regulator for R-Ras activation and R-
Ras-mediated axonal growth in this study.
The importance of precise control of neuronal morphology in brain
function has long been recognized, as axonal morphological disruption
is likely responsible for disease progression. In the animal model of
epilepsy, aberrant axonal branches were directed to inappropriate re-
gions in the granule cells in the dentate gyrus [40]. In addition, axonal
loss is known to be an early pathological feature in many neurode-
generative disorders [41]. BDNF has been widely studied and re-
cognized as an important neurotrophic factor in the regulation of
neuronal growth, survival, and morphology [13]. It is also known that a
low circulating BDNF level is associated with a wide range of neu-
ropsychiatric disorders, including depression and bipolar disorder
[15,16]. However, the detailed downstream molecular mechanisms of
BDNF-induced neuronal growth are not well understood. In the current
study, a pull-down assay and morphological observations revealed that
BDNF regulates axonal morphology through R-Ras activation, and this
activity may be important for the precise neuronal network formation.
Given the relationships between axonal morphology and brain function,
BDNF-induced positive eﬀects on R-Ras activation and R-Ras-mediated
axonal growth at the cellular level may partially account for the ben-
eﬁcial eﬀects of BDNF on brain health. Additional studies are required
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to further elucidate the importance of BDNF-R-Ras signaling in vivo,
which will enhance our understanding of the physiological role of
BDNF and its therapeutic potential for improving brain health.
RasGRF1, one of the GEFs for Ras family small GTPases, is highly
expressed in the brain, and has important functions for learning and
memory [20,21]. At the cellular level, RasGRF1-mediated signaling
pathways are linked to diverse cellular functions such as the control of
cell growth and neurite outgrowth. In neurons, RasGRF1 was reported
to be expressed in postsynaptic densities [42]. In addition, RasGRF1 is a
binding partner of plasticity related gene 3 (PRG3), and functions in
PRG3-induced ﬁlopodia formation and axonal growth [43]. These ob-
servations suggest that RasGRF1 plays a role in the regulation of neu-
ronal morphology. Our knockdown and overexpression experiments
indicated that RasGRF1 is involved in the BDNF-induced promotion of
axonal growth. The ectopic expression of RasGRF1 alone signiﬁcantly
promoted axonal growth, suggesting that RasGRF1 has positive eﬀects
on axonal growth via interactions with endogenous R-Ras or some other
small GTPases, such as Rac1, under basal conditions.
RasGRF1 becomes phosphorylated at several sites by a variety of
intracellular kinases in response to several extracellular stimuli. NGF,
forskolin, serotonin, and NMDA stimulation are known to trigger the
phosphorylation of RasGRF1 at Ser916/898 [25–28]. This phosphor-
ylation is dependent on PKA activity and is associated with a signiﬁcant
increase in its intrinsic GEF activity against Ras proteins. Replacement
of Ser916/898 with alanine inhibits the full activation of GEF activity
induced by carbachol in NIH-3T3/hm1 ﬁbroblasts, suggesting that this
phosphorylation is necessary for the maximum GEF activity [25]. The
Ser916/898 phosphorylation site in RasGRF1 is conserved in rodents
and humans, but is absent in RasGRF2. Therefore, this phosphorylation-
mediated regulatory mechanism is one of the unique signal transduc-
tion pathways of RasGRF1 that cannot be replaced by RasGRF2. In the
present study, we newly found that BDNF-TrkB signaling also induced
phosphorylation of RasGRF1 at Ser916/898 by PKA. Moreover, we
observed a slight increase in the intracellular cAMP level after BDNF
treatment, which is consistent with previous reports [36]. Therefore, it
is reasonable to consider BDNF-TrkB stimulation as the trigger of the
local increase in cAMP level, leading to PKA activation and PKA-in-
duced RasGRF1 phosphorylation, which in turn, fully activate R-Ras.
Several other putative phosphorylation sites have been identiﬁed or
suggested in RasGRF1. RasGRF1 is known to be phosphorylated at
tyrosine residues by Trk receptors, Src, and Ack1, leading to regulation
of its GEF activity [34,44–46]. For example, Src-induced tyrosine
phosphorylation increases Rac-GEF activity but not Ras-GEF activity.
On the other hand, Ack1-induced tyrosine phosphorylation increases
Ras-GEF activity but not Rac-GEF activity. These reports suggest that
RasGRF1 possesses multiple tyrosine phosphorylation sites with distinct
eﬀects. Furthermore, the morphology of PC12 cells was reported to be
regulated by coordinated activation of H-Ras and Rac1 induced by
RasGRF1 [47], suggesting that harmonized regulation of Ras and Rac
activity by RasGRF1 is required for eﬀective control of cell morphology.
To date, however, the functional relationships between phosphoryla-
tion events on RasGRF1 at serines and tyrosines are unknown. As
RasGRF1 has many phosphorylated sites induced by diﬀerent extra-
cellular stimuli, RasGRF1 may orchestrate several signaling cascades
required for small GTPases-mediated biological eﬀects. Future studies
should investigate the molecular mechanisms underlying the cross-talk
between serine and tyrosine phosphorylation of RasGRF1 that regulate
diverse extracellular stimulation-initiated morphological changes in
neurons.
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